Renaissance Technologies’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Renaissance Technologies’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-98,700	Closed	-$1.44M	–	4443
2023 Q1	$1.44M	Buy	98,700 +50,700	+106%	+$717K	﹤0.01%	2231
2022 Q4	$350K	Buy	48,000 +300	+0.6%	+$2.12K	﹤0.01%	3159
2022 Q3	$330K	Buy	47,700 +800	+2%	+$5.97K	﹤0.01%	3165
2022 Q2	$328K	Buy	46,900 +21,100	+82%	+$165K	﹤0.01%	3401
2022 Q1	$213K	Buy	25,800 +7,900	+44%	+$71.3K	﹤0.01%	3625
2021 Q4	$193K	Buy	+17,900	New	+$193K	﹤0.01%	3523
2021 Q3	–	Sell	-22,300	Closed	-$270K	–	3974
2021 Q2	$270K	Buy	+22,300	New	+$277K	﹤0.01%	3178

Renaissance Technologies's AMYT Position: Q2 2023 in Review

Renaissance Technologies sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 98,700 shares — an estimated $1.44M sold.

Renaissance Technologies first reported a position in AMYT in Q2 2021 and held it in 7 quarters. The position peaked at $1.44M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Renaissance Technologies reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Renaissance Technologies sold 98,700 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $1.44M.
Renaissance Technologies first reported a position in Amryt Pharma plc American Depositary Shares in Q2 2021 and held it in 7 quarters.
Renaissance Technologies's Amryt Pharma plc American Depositary Shares position peaked at $1.44M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.